tradingkey.logo
搜索

Lantheus Holdings Inc

LNTH
添加自选
93.060USD
+2.060+2.26%
收盘 05/08, 16:00美东报价延迟15分钟
6.06B总市值
22.01市盈率 TTM

Lantheus Holdings Inc

93.060
+2.060+2.26%

关于 Lantheus Holdings Inc 公司

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, Neuraceq, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, among others. The Neuraceq (florbetaben F18 injection) is an F-18 PET imaging agent for Alzheimer’s disease.

Lantheus Holdings Inc简介

公司代码LNTH
公司名称Lantheus Holdings Inc
上市日期Jun 25, 2015
CEOMarkison (Brian A)
员工数量808
证券类型Ordinary Share
年结日Jun 25
公司地址331 Treble Cove Road
城市NORTH BILLERICA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编01862
电话19786718001
网址https://www.lantheus.com/
公司代码LNTH
上市日期Jun 25, 2015
CEOMarkison (Brian A)

Lantheus Holdings Inc公司高管

名称
名称/职务
职务
持股
持股变动
Ms. Mary Anne Heino
Ms. Mary Anne Heino
Executive Chairman of the Board, Interim Executive Officer
Executive Chairman of the Board, Interim Executive Officer
664.74K
+9.89%
Mr. Brian A. Markison
Mr. Brian A. Markison
Chief Executive Officer, Director
Chief Executive Officer, Director
180.68K
-28.64%
Dr. Jean-Claude Provost, M.D.
Dr. Jean-Claude Provost, M.D.
Chief Scientific Officer
Chief Scientific Officer
38.84K
-46.09%
Dr. James H. (Jim) Thrall
Dr. James H. (Jim) Thrall
Independent Director
Independent Director
33.21K
-7.64%
Dr. Gerard Ber, Ph.D.
Dr. Gerard Ber, Ph.D.
Independent Director
Independent Director
20.82K
-12.18%
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
7.36K
-34.47%
Dr. Phuong Khanh (P. K.) Morrow, M.D.
Dr. Phuong Khanh (P. K.) Morrow, M.D.
Independent Director
Independent Director
563.00
-450.62%
Mr. Samuel R. (Sam) Leno
Mr. Samuel R. (Sam) Leno
Independent Director
Independent Director
--
--
Ms. Julie H. Mchugh
Ms. Julie H. Mchugh
Lead Independent Director
Lead Independent Director
--
--
Mr. Gary John Pruden
Mr. Gary John Pruden
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Mary Anne Heino
Ms. Mary Anne Heino
Executive Chairman of the Board, Interim Executive Officer
Executive Chairman of the Board, Interim Executive Officer
664.74K
+9.89%
Mr. Brian A. Markison
Mr. Brian A. Markison
Chief Executive Officer, Director
Chief Executive Officer, Director
180.68K
-28.64%
Dr. Jean-Claude Provost, M.D.
Dr. Jean-Claude Provost, M.D.
Chief Scientific Officer
Chief Scientific Officer
38.84K
-46.09%
Dr. James H. (Jim) Thrall
Dr. James H. (Jim) Thrall
Independent Director
Independent Director
33.21K
-7.64%
Dr. Gerard Ber, Ph.D.
Dr. Gerard Ber, Ph.D.
Independent Director
Independent Director
20.82K
-12.18%
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
7.36K
-34.47%

收入明细

FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
PYLARIFY
989.12M
0.00%
DEFINITY
330.25M
0.00%
TechneLite
86.80M
0.00%
Strategic partnerships and other
59.38M
0.00%
Neuraceq
51.45M
0.00%
其他
-1.52B
100.00%
由于公司未披露,未能获取相关数据
业务
地区
业务USD
名称
营收
占比
PYLARIFY
989.12M
0.00%
DEFINITY
330.25M
0.00%
TechneLite
86.80M
0.00%
Strategic partnerships and other
59.38M
0.00%
Neuraceq
51.45M
0.00%
其他
-1.52B
100.00%

股东统计

更新时间: 5月7日 周四
更新时间: 5月7日 周四
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
11.07%
The Vanguard Group, Inc.
10.10%
Janus Henderson Investors
8.77%
Farallon Capital Management, L.L.C.
8.34%
Fidelity Management & Research Company LLC
4.70%
其他
57.03%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
11.07%
The Vanguard Group, Inc.
10.10%
Janus Henderson Investors
8.77%
Farallon Capital Management, L.L.C.
8.34%
Fidelity Management & Research Company LLC
4.70%
其他
57.03%
股东类型
持股股东
占比
Investment Advisor
50.31%
Investment Advisor/Hedge Fund
35.69%
Hedge Fund
15.41%
Research Firm
4.24%
Individual Investor
2.04%
Sovereign Wealth Fund
1.76%
Pension Fund
1.62%
Bank and Trust
0.70%
Family Office
0.09%

机构持股

更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
1043
77.80M
119.49%
-5.94M
2025Q4
1032
71.64M
108.04%
-15.51M
2025Q3
1018
78.96M
119.07%
-8.67M
2025Q2
1039
82.20M
120.88%
-4.84M
2025Q1
1066
83.20M
120.27%
-2.89M
2024Q4
1033
78.65M
114.86%
-4.64M
2024Q3
1003
73.69M
106.06%
-7.92M
2024Q2
959
71.82M
103.63%
-10.29M
2024Q1
912
71.21M
103.87%
-11.25M
2023Q4
868
73.50M
107.32%
-9.24M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
7.21M
11.09%
-83.15K
-1.14%
Dec 31, 2025
The Vanguard Group, Inc.
6.67M
10.26%
-253.04K
-3.66%
Dec 31, 2025
Janus Henderson Investors
5.71M
8.78%
-977.49K
-14.62%
Dec 31, 2025
Farallon Capital Management, L.L.C.
5.43M
8.35%
+1.95M
+56.09%
Dec 31, 2025
Fidelity Management & Research Company LLC
3.06M
4.71%
-43.57K
-1.40%
Dec 31, 2025
State Street Investment Management (US)
2.43M
3.74%
-69.77K
-2.79%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.73M
2.66%
-27.98K
-1.59%
Dec 31, 2025
Reinhart Partners, LLC
1.56M
2.4%
+214.82K
+15.94%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
1.42M
2.18%
+44.37K
+3.24%
Dec 31, 2025
Swedbank Robur Fonder AB
1.23M
1.89%
--
--
Dec 31, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
State Street SPDR S&P Health Care Equipment ETF
1.96%
Invesco S&P MidCap 400 GARP ETF
1.69%
First Trust Small Cap US Equity Select ETF
1.07%
VictoryShares Small Cap Free Cash Flow ETF
0.93%
Invesco S&P MidCap 400 Pure Growth ETF
0.74%
Distillate Small/Mid Cash Flow ETF
0.66%
Pacer US Small Cap Cash Cows ETF
0.56%
Gotham 1000 Value ETF
0.5%
Invesco S&P MidCap Quality ETF
0.47%
Pacer US Cash Cows Growth ETF
0.47%
查看更多
State Street SPDR S&P Health Care Equipment ETF
占比1.96%
Invesco S&P MidCap 400 GARP ETF
占比1.69%
First Trust Small Cap US Equity Select ETF
占比1.07%
VictoryShares Small Cap Free Cash Flow ETF
占比0.93%
Invesco S&P MidCap 400 Pure Growth ETF
占比0.74%
Distillate Small/Mid Cash Flow ETF
占比0.66%
Pacer US Small Cap Cash Cows ETF
占比0.56%
Gotham 1000 Value ETF
占比0.5%
Invesco S&P MidCap Quality ETF
占比0.47%
Pacer US Cash Cows Growth ETF
占比0.47%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI